There is no specific publicly available information about what designer furniture Emmanuelle Charpentier dreams of owning. As a prominent scientist, her focus has primarily been on her research and advocacy for ethical biotechnology practices rather than personal luxury items.
Emmanuelle Charpentier co-founded CRISPR Therapeutics in 2013 alongside Rodger Novak and Shaun Foy. The company focuses on developing the CRISPR-Cas genome engineering technology for applications in biotechnology and biomedicine. This groundbreaking approach has positioned CRISPR Therapeutics at the forefront of gene-editing therapies.
EN